Biology subjects

Grassi, F.

Publications and source records attributed to Grassi, F..

3 recordsLinked to original sources

bioRxiv2025

Mapping social relevance in affective scenes: A large-scale multidimensional rating study

Understanding how individuals evaluate social content in affective scenes is crucial for research in emotion, social cognition, and decision-making. However, standardized image databases often lack fine-grained ratings of social dimensions beyond basic emotional content. We present a normative dataset of 296 affective scenes rated by 424 adult participants across six social-affective dimensions: social relevance, emotion sharing, action sharing, interpersonal equality, scene pleasantness, and participatory arousal. Each image was independently coded for objective features such as number of people, face visibility, and gaze direction. All rating dimensions showed excellent interrater reliability. Pleasantness ratings demonstrated strong convergent validity with established valence norms from the International Affective Picture System (IAPS), while arousal ratings differentiated between experienced and participatory arousal, suggesting that the latter captures a distinct affective component. Correlation analyses revealed that social relevance was strongly predicted by scene pleasantness and a composite "engagement" factor combining emotion sharing, action sharing, and equality. Notably, the association between pleasantness and social relevance was especially pronounced in scenes depicting single individuals. Linear mixed models further indicated that extraversion modestly amplified the relationship between engagement and social relevance, while other personality traits and empathy did not significantly affect ratings. This open-access dataset provides a reliable, multidimensional tool for selecting affective scenes based on both emotional and social-interpersonal features. It supports improved stimulus control and design in a wide range of behavioral and neurocognitive research. By systematically mapping social meaning in static affective scenes, our study advances existing methodological resources and offers empirical insight into the structure of social-affective appraisals. All image codes, mean ratings, and analysis scripts are publicly available via the Open Science Framework.

neuroscience↗

bioRxiv2022

Macrophages and glia are the dominant P2X7-expressing cell types in the gut nervous system - no evidence for a role of neuronal P2X7 receptors in colitis

SummaryBlockade or deletion of the pro-inflammatory P2X7 receptor channel has been shown to reduce tissue damage and symptoms in models of inflammatory bowel disease (IBD) and P2X7 receptors on enteric neurons were suggested to mediate neuronal death and associated motility changes. Here we used P2X7-specific antibodies and nanobodies as well as a BAC transgenic P2X7-EGFP reporter mouse model and P2rx7-/- controls to perform a detailed analysis of cell type-specific P2X7 expression and possible overexpression effects in the enteric nervous system. In contrast to previous studies, we did not detect P2X7 in neurons but found dominant expression in glia and macrophages which closely interact with the neurons. P2X7 overexpression per se did not induce significant pathological effects. Our data indicate that macrophages and/or glia account for P2X7-mediated neuronal damage in IBD and provide a refined basis for the exploration of P2X7-based therapeutic strategies.

physiology↗

bioRxiv2021

Expression and Manufacturing of Protein Therapeutics in Spirulina

Arthrospira platensis (commonly known as spirulina) is a photosynthetic cyanobacterium1. It is a highly nutritious food that has been consumed for decades in the US, and even longer by indigenous cultures2. Its widespread use as a safe food source and proven scalability have driven frequent attempts to convert it into a biomanufacturing platform. But these were repeatedly frustrated by spirulinas genetic intractability. We report here efficient and versatile genetic engineering methodology for spirulina that allows stable expression of bioactive protein therapeutics at high levels. We further describe large-scale, indoor cultivation and downstream processing methods appropriate for the manufacturing of biopharmaceuticals in spirulina. The potential of the platform is illustrated by pre-clinical development and human testing of an orally delivered antibody therapeutic against campylobacter, a major cause of infant mortality in the developing world and a growing antibiotic resistance threat3,4. This integrated development and manufacturing platform blends the safety of food-based biotechnology with the ease of genetic manipulation, rapid growth rates and high productivity characteristic of microbial platforms. These features combine for exceptionally low-cost production of biopharmaceuticals to address medical needs that are unfeasible with current biotechnology platforms.

molecular biology↗